A flourishing research field, cell-based therapy involves modifying a patient’s own cells or cells from a donor to fight disease and alleviate medical conditions. In recent years, we helped pioneer a landmark cell-based approach, known as chimeric antigen receptor therapy, to treat blood cancers. We continue to investigate an expanding array of cell types for novel therapeutic uses.
Pictured: Immature nerve cells generated from induced pluripotent stem cells by cell engineering. Memorial Sloan Kettering researchers are at the forefront of developing cell-based therapies for cancer and other diseases, including central nervous system disorders. (Courtesy of the Lorenz Studer lab.)